4571.T

Healthcare Biotechnology

Nano Holdings, Inc.

¥84.00

-9.00 -9.68% today

Price History

Not enough data

Key Stats

Market Cap

7.03B

Avg Volume

415,539

EPS

-¥12.77

52W High

¥254.00

52W Low

¥80.00

Div. Yield

0.0%

Valuation

Forward P/E

-3.46

P/B Ratio

2.12

P/S Ratio

34.79

EV/Revenue

23.91

Margins

Gross Margin 88.6%

Operating Margin (788.6%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

400.0%

Return on Equity

(34.3%)

Return on Assets

(14.3%)

Liquidity & Leverage

Current Ratio

6.82

Quick Ratio

6.40

Debt / Equity

0.36

Total Cash

4.22B

Total Debt

1.20B

About

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.